8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Nanoparticle-EMF synergism: a study on the combined effects on developmental and behavioral endpoints in Drosophila melanogaster

Bioeffects Seen

Bhandari M, Anand AS, Verma K, Regmi K, Amitabh, Prasad DN, Kohli E · 2025

Share:

Combined EMF and nanoparticle exposure produced complex, dose- and time-dependent biological responses in fruit flies, including both detrimental effects (behavioral impairment, oxidative stress) and protective effects on survival depending on exposure parameters.

Plain English Summary

Summary written for general audiences

This study examined the combined effects of 2.4 GHz electromagnetic field (EMF) exposure and zinc oxide nanoparticle (NP) ingestion on fruit flies (Drosophila melanogaster) across multiple generations, measuring outcomes including survival, motor function, oxidative stress, memory, and physical abnormalities. Results showed that 20-minute EMF exposure improved survival in flies exposed to high-dose nanoparticles, while EMF alone caused behavioral impairments and elevated oxidative stress, with some effects reversing in subsequent generations.

Why This Matters

This study uses Drosophila melanogaster as a model organism to investigate potential interactive effects between environmental stressors, an approach commonly used in toxicology and developmental biology research. The findings suggest that combined exposures warrant investigation beyond single-agent studies, though results in invertebrate models require careful interpretation when considering relevance to mammalian systems.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Bhandari M, Anand AS, Verma K, Regmi K, Amitabh, Prasad DN, Kohli E (2025). Nanoparticle-EMF synergism: a study on the combined effects on developmental and behavioral endpoints in Drosophila melanogaster.
Show BibTeX
@article{bhandari_m_anand_as_verma_k_regmi_k_amitabh_prasad_dn_kohli_e_ce3169,
  author = {Bhandari M and Anand AS and Verma K and Regmi K and Amitabh and Prasad DN and Kohli E},
  title = {Nanoparticle-EMF synergism: a study on the combined effects on developmental and behavioral endpoints in Drosophila melanogaster},
  year = {2025},
  doi = {10.1016/s1473-3099(25)00093-3},
  
}
DOI: 10.1016/s1473-3099(25)00093-3PubMed: 41036120

Quick Questions About This Study

The trial was stopped due to low recruitment. Only 923 participants joined the molnupiravir comparison and 137 joined the nirmatrelvir-ritonavir comparison, far fewer than needed for definitive conclusions about treatment effectiveness.
No significant reduction was found. Death rates were identical at 17% for both molnupiravir-treated patients and those receiving usual care alone. The hazard ratio was 0.93, indicating no meaningful difference.
The study found no benefit. Death rates were identical at 19% for both nirmatrelvir-ritonavir and usual care groups. However, the very small sample size (137 total participants) limited statistical power.
Yes, more than three-quarters of participants were vaccinated and had antispike antibodies at randomization. Additionally, more than two-thirds were already receiving other SARS-CoV-2 antiviral treatments alongside the study drugs.
No. The researchers acknowledged that low recruitment meant "a clinically meaningful benefit of treatment could not be ruled out," especially for nirmatrelvir-ritonavir. Larger studies would be needed for definitive safety conclusions.